Biotechnology News
| |
Arrowhead
Conferences' Drug Delivery 2007 to Take Place April 9th-11th
2007 in San Francisco
|
|
|
| Drug Delivery 2007 has been organized
to provide a critical examination of the drug delivery
industry as well as insight from key industry leaders
concerning cutting edge drug delivery technology, structuring
mutually beneficial deals and the drug delivery industry's
impact on the field of biote... |
|
|
02/19/2007
02:28pm - PR
Web: Biotechnology
|
|
|
| |
Biotech
Week in Review: Onyx Is Star of the Week
|
|
|
| Centient Biotech Investor submits: A very
minor advance was the best that biotech could do last
week. The Centient Biotech 200TM rose just 4 points, which
equates to a small one-tenth of one percentage point,
ending at 4054. That is not much in the way of change.
But even if last week was n... |
|
|
02/19/2007
02:19pm - SeekingAlpha
Biotech Stocks
|
|
|
| |
Pro-Pharmaceuticals
seeks early market clearance to boost biz
|
|
|
| With available cash just months away from
running dry, Newton-based biotechnology firm Pro-Pharmaceuticals
Inc. this week submitted an early application to the U.S.
Food and Drug Administration to gain market clearance
for the use of its lead cancer drug, Davanat, in combination
with an approved... |
|
|
02/19/2007
11:46am - BizJournals.com:
Biotechnology
|
|
|
| |
What
became of last year's grants?
|
|
|
| Art students don't exactly come to mind
as being probable candidates for biotechnology internships,
but Salem College wanted to break that mold. |
|
|
02/19/2007
11:46am - BizJournals.com:
Biotechnology
|
|
|
| |
Elixir
Pharmaceuticals and Siena Biotech S.p.A. enter Agreement
to Evaluate SIRT1 Inhibitors in Huntington's Disease
|
|
|
| Elixir Pharmaceuticals, Inc. and Siena
Biotech S.p.A. announced that the two companies have entered
into an agreement to collaborate on the optimization,
validation and evaluation of Elixir's SIRT1 ... |
|
|
02/19/2007
05:22am - Bionity.com
|
|
|
| |
Complaint
Properly Shows That Defendants' Statements Were Misleading,
Investors Argue
|
|
|
| PHILADELPHIA - A complaint filed by investors
of biotechnology company Discovery Laboratories Inc. should
not be dismissed because the investors have properly shown
that the defendants issued a series of misrepresentations
in violation of federal securities laws and acted with
scienter, the inve... |
|
|
02/18/2007
09:12am - LexisNexis
Mealey Emerging Securities Litigation Legal News
|
|
|
| |
Amazon
Biotech, Inc.: Harbinger Research Issues Research Brief
for Amazon Biotech Inc. With a Speculative Buy Rating
and Price Target of $0.25
|
|
|
| NEW YORK, NY (MARKET WIRE) Harbinger Research
LLC, www.harbingerresearch.com, an independent research
firm, issued a Research Brief today for Amazon Biotech,
Inc. (OTCBB: AMZB), a development stage pharmaceutical/biotech
company that is developing an all natural drug (AMZ 0026)
for the treatmen... |
|
|
02/17/2007
06:09am - MarketWire:
Pharmaceuticals and Biotech
|
|
|
| |
Amazon
Biotech, Inc: Amazon Biotech, Inc. Announces Issuance
of Patent for a Unique Formulation and Method of Treating
HIV Infection
|
|
|
| NEW YORK, NY (MARKET WIRE) Amazon Biotech,
Inc. (OTCBB: AMZB) (FRANKFURT: B2D) announced that it
has been issued a patent from the United States Patent
and Trademark Office, patent # 7,160,561 for "a herbal
composition and method of treating HIV infection. |
|
|
02/17/2007
04:03am - MarketWire:
Pharmaceuticals and Biotech
|
|
|
| |
GPC
Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin
|
|
|
| Martinsried/Munich (Germany), Waltham,
Mass. and Princeton, N.J., February 16, 2007 — GPC
Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index;
NASDAQ: GPCB) today announced that the Company has co...
[WebWire - Friday, February 16, 2007] |
|
|
02/16/2007
09:33pm - WebWire(R)
- Health Care/Hospitals
|
|
|
| |
MediGene
Obtains European Patent on EndoTAGTM-1
|
|
|
| Martinsried/Munich, February 16, 2007.
Today the German-American biotech company MediGene AG
(Frankfurt, Prime Standard: MDG) announced that the European
patent office has granted a patent covering th... [WebWire
- Friday, February 16, 2007] |
|
|
02/16/2007
09:33pm - WebWire(R)
- Health Care/Hospitals
|
|
|
| |
Q
& A :: RE: stevia plants available@1.10 per plant
|
|
|
| Author: kirti s Posted: Fri Feb 16, 2007
1:46 pm (GMT 0) Topic Replies: 2 Hello Sir Sir the below
concerned has a buy bac scheme for stevia. Ayurmeda Biotech
Pvt ltd Vinod Haritwal 31, New silver home 15 New Kantwadi
road Bandra West Mumbai MH 912226421551 ... |
|
|
02/16/2007
08:48pm - AgricultureInformation.com
|
|
|
| |
GPC
Biotech seeks FDA OK for prostate cancer drug
|
|
|
| GPC Biotech AG, a German firm with offices
in Waltham, has submitted an application to the U.S. Food
and Drug Administration to gain approval for its drug
satraplatin as a treatment for prostate cancer, officials
report. |
|
|
02/16/2007
11:15pm - BizJournals.com:
Biotechnology
|
|
|
| |
TaiGen
Appoints Dr. Luke Lin VP of Clinical Research & Development
|
|
|
| TAIPEI, Taiwan, Feb. 14 /Xinhua-PRNewswire-FirstCall/
-- TaiGen Biotechnology Inc., a private Taiwan based biopharmaceutical
company developing novel therapeutics to treat infectious
diseases, cancer and diabetic complications, today announced
the appointment of Dr. Luke Lin as Vice President of... |
|
|
02/16/2007
08:43pm - Drug
Newswire
|
|
|
| |
Cougar
Biotechnology Names Richard B. Phillips, Ph.D. Vice President
of Regulatory Affairs and Quality Assurance
|
|
|
| Los Angeles, CA, February 14, 2007 /PRNewswire-FirstCall/
-- Cougar Biotechnology, Inc. (BULLETIN BOARD: CGRB) ,
a biotechnology company focused on acquiring and developing
oncology drug candidates, today announced the appointment
of Richard B. Phillips, Ph.D., to the position of Vice
President ... |
|
|
02/16/2007
07:18pm - Drug
Newswire
|
|
|
| |
Q
& A :: RE: Safed Masuli roots for Planting
|
|
|
| Author: kirti s Posted: Fri Feb 16, 2007
1:07 pm (GMT 0) Topic Replies: 3 Dear Sir U may please
contact the below concerned for the required information
Shah And Patil Farms Sellers of aloevera plants, leaves
and gel, amla fresh and powder and safed musli roots.
Addres... |
|
|
02/16/2007
07:15pm - AgricultureInformation.com
|
|
|
| |
First
Patients Undergo Surgery in Northwest Biotherapeutics'
Phase II Brain Cancer Trial
|
|
|
| Personalized Cancer Immunotherapy for
Glioblastoma Multiforme BOTHELL, Wash., Feb. 13 /PRNewswire-FirstCall/
-- Northwest Biotherapeutics, Inc. (BULLETIN BOARD: NWBT.OB)
, a biotechnology company focused on cancer immunotherapy,
today announced that the first two patients in its pivotal
... |
|
|
02/16/2007
01:36pm - Drug
Newswire
|
|
|
| |
BioVeris
Launches New Products for Life Sciences
|
|
|
| Cytokine Biomarkers and Antibody Panels
Introduced For Sale GAITHERSBURG, Md., Feb. 13 /PRNewswire-FirstCall/
-- BioVeris Corporation (NASDAQ:BIOV) announced today
that it has introduced for sale eight new products for
use in life science research. These new products are focused
on meeti... |
|
|
02/16/2007
01:36pm - Drug
Newswire
|
|
|
| |
EFFECTS
AND VALUE OF VERIFIABLE INFORMATION IN A CONTROVERSIAL
MARKET: EVIDENCE FROM LAB AUCTIONS OF GENETICALLY MODIFIED
FOOD
|
|
|
| http://www.blackwell-synergy.com/doi/abs/10.1111/j.1465-7295.2007.00017.x
Abstract: Food products containing genetically modified
(GM) ingredients have entered the market over the past
decade. The biotech industry and environmental groups
have disseminated conflicting private information about
G... |
|
|
02/16/2007
10:21am - Environmental
Valuation Cost Benefit News
|
|
|
|
|
|
|
|
|
SEARCH